-+ 0.00%
-+ 0.00%
-+ 0.00%

Hoth Therapeutics Receives USPTO Notice of Allowance for Novel Exon-Skipping Therapy Patent Targeting Allergic Diseases

Reuters·02/12/2026 13:33:16

Please log in to view news